How to switch from Abilify Maintena to Aristada?
Abilify Maintena (aripiprazole) and Aristada (aripiprazole lauroxil) contain an atypical antipsychotic. They are both used to treat adults with schizophrenia.
Aristada contains aripiprazole lauroxil - a prodrug of aripiprazole - which is the active ingredient in Abilify Maintena. When patients take Aristada, aripiprazole lauroxil is converted to aripiprazole by the body.
Abilify Maintena and Aristada are extended release (depot) injections that are administered by a healthcare professional into the patient’s deltoid or gluteal muscle.
Switching from Abilify Maintena to Aristada
The recommended starting and maintenance dose of Abilify Maintena is 400mg a month. It takes four doses to reach steady state concentrations of the drug - for the amount of the drug being absorbed to match the amount being cleared from the body.
Patients stabilized on Abilify Maintena 400 mg a month who have reached steady state concentrations can be switched to Aristada 882 mg four weeks after their last Abilify Maintena 400 mg intramuscular injection.
Why switch from Abilify Maintena to Aristada?
Although they both contain aripiprazole, sometimes people will need to switch from Abilify Maintena to Aristada because of:
Related medical questions
- Why should you take aripiprazole in the morning?
- How to switch from Abilify Maintena to Aristada?
- How is the Aristada injection given?
- Does Abilify cause weight gain?
- Why should you take aripiprazole in the morning?
- How to switch from Abilify Maintena to Aristada?
- How is the Aristada injection given?
- Does Abilify cause weight gain?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions